Alves, R., Gonçalves, A. C., Jorge, J., Almeida, A. M., & Sarmento-Ribeiro, A. B. (2022). Combination of elacridar with imatinib modulates resistance associated with drug efflux transporters in chronic myeloid leukemia.
Chicago Style CitationAlves, Raquel, Ana Cristina Gonçalves, Joana Jorge, António M. Almeida, and Ana Bela Sarmento-Ribeiro. Combination of Elacridar With Imatinib Modulates Resistance Associated With Drug Efflux Transporters in Chronic Myeloid Leukemia. 2022.
MLA CitationAlves, Raquel, et al. Combination of Elacridar With Imatinib Modulates Resistance Associated With Drug Efflux Transporters in Chronic Myeloid Leukemia. 2022.
Note: citation formatting may not correspond 100% to that defined by the respective standard, to manage citations it is recommended to use the software Zotero
, which allows the automatic upload of Oasisbr references.